145 related articles for article (PubMed ID: 34338949)
1. Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.
Ceravolo I; Barchetti G; Biraschi F; Gerace C; Pampana E; Pingi A; Stasolla A
Radiol Med; 2021 Nov; 126(11):1468-1476. PubMed ID: 34338949
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Shortly after a Normal Conventional Brain Magnetic Resonance Imaging: A Report of Two Cases and Review of the Literature.
Hakan T; Çelikoglu E
Asian J Neurosurg; 2021; 16(2):433-436. PubMed ID: 34268181
[TBL] [Abstract][Full Text] [Related]
3. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
4. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
Toh CH; Castillo M
AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
[TBL] [Abstract][Full Text] [Related]
5. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging.
Prada F; Vitale V; Del Bene M; Boffano C; Sconfienza LM; Pinzi V; Mauri G; Solbiati L; Sakas G; Kolev V; D'Incerti L; DiMeco F
Radiology; 2017 Oct; 285(1):242-249. PubMed ID: 28562204
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.
Ozturk K; Soylu E; Tolunay S; Narter S; Hakyemez B
World Neurosurg; 2019 Aug; 128():e195-e208. PubMed ID: 31003026
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.
Hwang I; Choi SH; Park CK; Kim TM; Park SH; Won JK; Kim IH; Lee ST; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2020 Jan; 41(1):49-56. PubMed ID: 31806595
[TBL] [Abstract][Full Text] [Related]
9. The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.
Lasocki A; Gaillard F; Tacey MA; Drummond KJ; Stuckey SL
J Neurooncol; 2016 Sep; 129(3):471-478. PubMed ID: 27412000
[TBL] [Abstract][Full Text] [Related]
10. Fractional Anisotropy Correlates with Overall Survival in Glioblastoma.
Huber T; Bette S; Wiestler B; Gempt J; Gerhardt J; Delbridge C; Barz M; Meyer B; Zimmer C; Kirschke JS
World Neurosurg; 2016 Nov; 95():525-534.e1. PubMed ID: 27565465
[TBL] [Abstract][Full Text] [Related]
11. Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study.
Currie S; Fatania K; Frood R; Whitehead R; Start J; Lee MT; McDonald B; Rankeillor K; Roberts P; Chakrabarty A; Mathew RK; Murray L; Short S; Scarsbrook A
Curr Oncol; 2023 Jul; 30(7):6682-6698. PubMed ID: 37504350
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging Features of Rhabdoid Glioblastomas.
Gelal MF; Rezanko TA; Sarp AF; Dirilenoğlu F; Güvenç G; Ölmezoğlu A
Clin Neuroradiol; 2016 Sep; 26(3):329-40. PubMed ID: 25516148
[TBL] [Abstract][Full Text] [Related]
13. Clinical Evaluation of a Multiparametric Deep Learning Model for Glioblastoma Segmentation Using Heterogeneous Magnetic Resonance Imaging Data From Clinical Routine.
Perkuhn M; Stavrinou P; Thiele F; Shakirin G; Mohan M; Garmpis D; Kabbasch C; Borggrefe J
Invest Radiol; 2018 Nov; 53(11):647-654. PubMed ID: 29863600
[TBL] [Abstract][Full Text] [Related]
14. Treatment results of glioblastoma during the last 30 years in a single institute.
Kumabe T; Saito R; Kanamori M; Chonan M; Mano Y; Shibahara I; Kawaguchi T; Kato H; Yamashita Y; Sonoda Y; Kawagishi J; Jokura H; Watanabe M; Katakura R; Kayama T; Tominaga T
Neurol Med Chir (Tokyo); 2013; 53(11):786-96. PubMed ID: 24140783
[TBL] [Abstract][Full Text] [Related]
15. MRI findings and pathological features in early-stage glioblastoma.
Ideguchi M; Kajiwara K; Goto H; Sugimoto K; Nomura S; Ikeda E; Suzuki M
J Neurooncol; 2015 Jun; 123(2):289-97. PubMed ID: 25939441
[TBL] [Abstract][Full Text] [Related]
16. A novel combination of double primary malignancies: penile carcinoma and glioblastoma. A series of two cases.
Eva L; Dobrovăţ BI; Haba D; Munteanu G; Indrei L; Dumitrescu N; Şerban IL
Rom J Morphol Embryol; 2018; 59(4):1067-1074. PubMed ID: 30845286
[TBL] [Abstract][Full Text] [Related]
17. Multicentric non-enhancing lesions in glioblastoma: A retrospective study.
Benouaich-Amiel A; Khasminsky V; Gal O; Weiss T; Fichman S; Kanner AA; Berkowitz S; Laviv Y; Mandel J; Dudnik E; Siegal T; Yust-Katz S
J Clin Neurosci; 2021 Mar; 85():20-26. PubMed ID: 33581785
[TBL] [Abstract][Full Text] [Related]
18. Rectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlation.
Jiang ZX; Zhang SJ; Peng WJ; Yu BH
World J Gastroenterol; 2013 May; 19(20):3108-16. PubMed ID: 23716991
[TBL] [Abstract][Full Text] [Related]
19. Differential Diagnostic Value of Texture Feature Analysis of Magnetic Resonance T2 Weighted Imaging between Glioblastoma and Primary Central Neural System Lymphoma.
Wang BT; Liu MX; Chen ZY
Chin Med Sci J; 2019 Mar; 34(1):10-17. PubMed ID: 30961775
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
Babu R; Hatef J; McLendon RE; Cummings TJ; Sampson JH; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):412-9. PubMed ID: 23641829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
